HuGE Literature Finder
Records 1-30
|
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Acta neuropathologica communications 2020 Nov 8 (1): 201. Arita Hideyuki, Matsushita Yuko, Machida Ryunosuke, Yamasaki Kai, Hata Nobuhiro, Ohno Makoto, Yamaguchi Shigeru, Sasayama Takashi, Tanaka Shota, Higuchi Fumi, Iuchi Toshihiko, Saito Kuniaki, Kanamori Masayuki, Matsuda Ken-Ichiro, Miyake Yohei, Tamura Kaoru, Tamai Sho, Nakamura Taishi, Uda Takehiro, Okita Yoshiko, Fukai Junya, Sakamoto Daisuke, Hattori Yasuhiko, Pareira Eriel Sandika, Hatae Ryusuke, Ishi Yukitomo, Miyakita Yasuji, Tanaka Kazuhiro, Takayanagi Shunsaku, Otani Ryohei, Sakaida Tsukasa, Kobayashi Keiichi, Saito Ryuta, Kurozumi Kazuhiko, Shofuda Tomoko, Nonaka Masahiro, Suzuki Hiroyoshi, Shibuya Makoto, Komori Takashi, Sasaki Hikaru, Mizoguchi Masahiro, Kishima Haruhiko, Nakada Mitsutoshi, Sonoda Yukihiko, Tominaga Teiji, Nagane Motoo, Nishikawa Ryo, Kanemura Yonehiro, Kuchiba Aya, Narita Yoshitaka, Ichimura Koic |
|
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
|
Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Neuropathology and applied neurobiology 2020 Jul . Petersen Jeanette K, Boldt Henning B, Sørensen Mia D, Blach Steffi, Dahlrot Rikke H, Hansen Steinbjørn, Burton Mark, Thomassen Mads, Kruse Torben, Poulsen Frantz R, Andreasen Lotte, Hager Henrik, Ulhøi Benedicte P, Lukacova Slavka, Reifenberger Guido, Kristensen Bjarne |
|
Adult Diffuse Glioma GWAS by Molecular Subtype Identifies Variants in D2HGDH and FAM20C.
Neuro-oncology 2020 May . Eckel-Passow Jeanette E, Drucker Kristen L, Kollmeyer Thomas M, Kosel Matt L, Decker Paul A, Molinaro Annette M, Rice Terri, Praska Corinne E, Clark Lauren, Caron Alissa, Abyzov Alexej, Batzler Anthony, Song Jun S, Pekmezci Melike, Hansen Helen M, McCoy Lucie S, Bracci Paige M, Wiemels Joseph, Wiencke John K, Francis Stephen, Burns Terry C, Giannini Caterina, Lachance Daniel H, Wrensch Margaret, Jenkins Robert |
|
Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients.
Brain and behavior 2020 Mar e01583. Qu Chong-Xiao, Ji Hong-Ming, Shi Xiang-Cheng, Bi Hong, Zhai Li-Qin, Han De- |
|
TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis.
Journal of neuropathology and experimental neurology 2020 Jan . Hewer Ekkehard, Phour Jaison, Gutt-Will Marielena, Schucht Philippe, Dettmer Matthias S, Vassella Er |
|
Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
Translational oncology 2019 Dec 13 (2): 346-354. Razis Evangelia, Kotoula Vassiliki, Koliou Georgia-Angeliki, Papadopoulou Kyriaki, Vrettou Eleni, Giannoulatou Eleni, Tikas Ioannis, Labropoulos Stefanos V, Rigakos Georgios, Papaemmanoyil Styliani, Romanidou Ourania, Bourkoula Eugenia, Nomikos Panagiotis, Iliadis Georgios, Nasioulas George, Selviaridis Panagiotis, Polyzoidis Konstantinos, Fountzilas Geor |
|
Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features.
Scientific reports 2019 Nov 9 (1): 16058. Zhang Longbo, Liu Zhiqiang, Li Jin, Huang Tianxiang, Wang Ying, Chang Lianpeng, Zheng Wenjie, Ma Yujie, Chen Fenghua, Gong Xuan, Yuan Qianying, Teaw Shannon, Fang Xinqi, Song Tao, Huo Lei, Li Xi, Xia Xuefeng, Liu Zhixiong, Wu J |
|
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
|
TERT rs10069690 polymorphism and cancers risk: A meta-analysis.
Molecular genetics & genomic medicine 2019 Aug e903. He Guisheng, Song Tao, Zhang Yazhen, Chen Xiuxiu, Xiong Wei, Chen Huamin, Sun Chuanwei, Zhao Chaoyang, Chen Yunjing, Wu Huang |
|
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse gliomarwith molecular genetic features of primary glioblastoma.
Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
|
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Cancer science 2018 May . Otani Ryohei, Uzuka Takeo, Higuchi Fumi, Matsuda Hadzki, Nomura Masashi, Tanaka Shota, Mukasa Akitake, Ichimura Koichi, Kim Phyo, Ueki Keisu |
|
Absence of TERT promoter mutations in colorectal precursor lesions and cancer.
Genetics and molecular biology 2018 Feb 0. Cruvinel-Carloni Adriana, Yamane Letícia, Scapulatempo-Neto Cristovam, Guimarães Denise, Reis Rui Manu |
|
TERT promoter hotspot mutations in breast cancer.
Breast cancer (Tokyo, Japan) 2017 Dec . Shimoi Tatsunori, Yoshida Masayuki, Kitamura Yuka, Yoshino Tomomi, Kawachi Asuka, Shimomura Akihiko, Noguchi Emi, Yunokawa Mayu, Yonemori Kan, Shimizu Chikako, Kinoshita Takayuki, Ichimura Koichi, Fukuda Takahiro, Fujiwara Yasuhiro, Tamura Ken |
|
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
Critical reviews in oncology/hematology 2017 Dec 120 1-9. Vuong Huy Gia, Altibi Ahmed M A, Duong Uyen N P, Ngo Hanh T T, Pham Thong Quang, Chan Aden Ka-Yin, Park Chul-Kee, Fung Kar-Ming, Hassell Lew |
|
Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
CNS neuroscience & therapeutics 2017 Oct 23 (10): 790-797. You Hao, Wu Yao, Chang Kai, Shi Xiao, Chen Xin-Da, Yan Wei, Li R |
|
The effects of gene polymorphisms on glioma prognosis.
The journal of gene medicine 2017 Oct . Cui Ying, Li Guolin, Yan Mengdan, Li Jing, Jin Tianbo, Li Shanqu, Mu Shij |
|
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Acta neuropathologica 2017 Mar . Pekmezci Melike, Rice Terri, Molinaro Annette M, Walsh Kyle M, Decker Paul A, Hansen Helen, Sicotte Hugues, Kollmeyer Thomas M, McCoy Lucie S, Sarkar Gobinda, Perry Arie, Giannini Caterina, Tihan Tarik, Berger Mitchel S, Wiemels Joseph L, Bracci Paige M, Eckel-Passow Jeanette E, Lachance Daniel H, Clarke Jennifer, Taylor Jennie W, Luks Tracy, Wiencke John K, Jenkins Robert B, Wrensch Margaret |
|
The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis.
Oncotarget 2017 Mar . Li Hui, Xu Yanyan, Mei Hua, Peng Liang, Li Xiaojie, Tang Jianzh |
|
TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population.
Oncotarget 2016 Nov 7 (45): 73781-73791. He Xue, Wei Yahui, Chen Zhengshuai, Zhu Xikai, Ma Lifeng, Zhang Ning, Zhang Yuan, Kang Longli, Yuan Dongya, Zhang Zongyong, Jin Tian |
|
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Journal of neuro-oncology 2016 May 127 (3): 483-92. Ghasimi Soma, Wibom Carl, Dahlin Anna M, Brännström Thomas, Golovleva Irina, Andersson Ulrika, Melin Beatri |
|
TERT Genetic Mutations as Prognostic Marker in Glioma.
Molecular neurobiology 2016 May . Geng Peiliang, Zhao Xiaoxin, Ou Juanjuan, Li Jianjun, Sa Rina, Liang Houj |
|
TERT mutation in glioma: Frequency, prognosis and risk.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016 Jan . Yuan Yang, Qi Chen, Maling Gou, Xiang Wang, Yanhui Liu, Ruofei Liang, Yunhe Mao, Jiewen Luo, Qing M |
|
Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
PloS one 2016 11 (1): e0146803. Yuan Ping, Cao Jin-Lin, Abuduwufuer Abudumailamu, Wang Lu-Ming, Yuan Xiao-Shuai, Lv Wang, Hu Ji |
|
Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
PloS one 2016 11 (10): e0163067. Dahlin Anna M, Wibom Carl, Ghasimi Soma, Brännström Thomas, Andersson Ulrika, Melin Beatri |
|
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
International journal of cancer 2016 07 139 (2): 414-23. Batista Rui, Cruvinel-Carloni Adriana, Vinagre João, Peixoto Joana, Catarino Telmo A, Campanella Nathalia Cristina, Menezes Weder, Becker Aline Paixão, de Almeida Gisele Caravina, Matsushita Marcus M, Clara Carlos, Neder Luciano, Viana-Pereira Marta, Honavar Mrinalini, Castro Lígia, Lopes José Manuel, Carvalho Bruno, Vaz Rui Manuel, Máximo Valdemar, Soares Paula, Sobrinho-Simões Manuel, Reis Rui Manuel, Lima Jor |
|
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.
Oncotarget 2015 Dec . Walsh Kyle M, Codd Veryan, Rice Terri, Nelson Christopher P, Smirnov Ivan V, McCoy Lucie S, Hansen Helen M, Elhauge Edward, Ojha Juhi, Francis Stephen S, Madsen Nils R, Bracci Paige M, Pico Alexander R, Molinaro Annette M, Tihan Tarik, Berger Mitchel S, Chang Susan M, Prados Michael D, Jenkins Robert B, Wiemels Joseph L, Telomere Group Engage Consortium, Samani Nilesh J, Wiencke John K, Wrensch Margaret |
|
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Oncotarget 2015 Nov . Gao Ke, Li Gang, Qu Yiping, Wang Maode, Cui Bo, Ji Meiju, Shi Bingyin, Hou Pe |
|
Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
Molecular neurobiology 2015 Sep . Wang Xiaogang, Li Xiaoming, Xu Feng, Zhang Youqian, Liu Hongwei, Tao Yingq |
|
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: